cannabidiol/tetrahydrocannabinol (T2:C100)
/ MediPharm Labs, University of Southern California
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
December 22, 2023
LiBBY: Life's End Benefits of Cannabidiol and Tetrahydrocannabinol
(clinicaltrials.gov)
- P2 | N=150 | Recruiting | Sponsor: University of Southern California | Not yet recruiting ➔ Recruiting
Enrollment open • Alzheimer's Disease • CNS Disorders • Dementia
December 01, 2023
LiBBY: Life's End Benefits of Cannabidiol and Tetrahydrocannabinol
(clinicaltrials.gov)
- P2 | N=150 | Not yet recruiting | Sponsor: University of Southern California
Trial completion date • Trial primary completion date • Alzheimer's Disease • CNS Disorders • Dementia
February 23, 2023
LiBBY: Life's End Benefits of Cannabidiol and Tetrahydrocannabinol
(clinicaltrials.gov)
- P2 | N=150 | Not yet recruiting | Sponsor: University of Southern California | Initiation date: Jan 2023 ➔ Jun 2023
Trial initiation date • Alzheimer's Disease • CNS Disorders • Dementia
1 to 3
Of
3
Go to page
1